InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Fowler Neal Franklin. Insider active across 2 companies, notably Aralez Pharmaceuticals Inc.. In total, 5 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €187k. Activity tracked since 3 October 2023. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Fowler Neal Franklin is a declarant linked to Emergent BioSolutions Inc. and Aralez Pharmaceuticals Inc., where he is listed as a Director. He has 5 filings in total, and in the sampled recent filings the sales amount to EUR 186959, with a date range from 2016-02-09 to 2025-05-02; the modal transaction nature is Attribution.